ZEUS System vs qXR-CTR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Qure.ai

AI Verdict

The ZEUS System specializes in AI-powered analysis of continuous ECG data from wearables for arrhythmia detection, such as Atrial Fibrillation. Conversely, qXR-CTR uses AI to automate cardiothoracic ratio measurement from chest X-ray images, focusing on heart size assessment and heart failure risk. While both are cardiology AI tools, they address different diagnostic needs and utilize distinct data types.

Choose ZEUS System if…

Choose ZEUS System if you require long-term, continuous cardiac monitoring to detect and characterize intermittent or asymptomatic arrhythmias, such as Atrial Fibrillation. This AI-powered solution is ideal for patients needing extended ECG data analysis from wearable biosensors to aid in early diagnosis and management of complex cardiac rhythm disorders.

View ZEUS System →

Choose qXR-CTR if…

Choose qXR-CTR if you need a rapid, automated assessment of heart size from standard chest X-ray images to screen for potential heart failure risk. This AI-powered tool is best suited for scenarios where quick and objective measurement of the cardiothoracic ratio is crucial for initial cardiac evaluation in a radiology or emergency setting.

View qXR-CTR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System qXR-CTR
Pricing Not disclosed Unknown
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware. Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

The ZEUS System integrates with Zio monitors, which are designed for patient simplicity and compliance, recording ECG data without patient interaction. Physicians can then access preliminary reports via the secure ZioSuite web portal, streamlining the workflow for long-term cardiac monitoring. This comprehensive approach to usability, encompassing both patient interaction and physician review, gives it an edge.

Clinical Value

ZEUS System

The ZEUS System offers continuous, long-term cardiac monitoring for up to 14 days, enabling early detection and characterization of arrhythmias like Atrial Fibrillation, including asymptomatic events. This proactive approach has significant potential for preventing serious cardiac events and improving patient outcomes. While qXR-CTR provides valuable automated measurements, ZEUS's continuous monitoring for dynamic conditions offers a broader clinical impact.

Pricing & Value

Tie

Neither Tool A nor Tool B publicly discloses their pricing information. Without any transparent pricing details or publicly available ROI studies, it is impossible to conduct a meaningful comparison of their pricing and overall value propositions.

Enterprise Readiness

qXR-CTR

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and Business Associate Agreements (BAA). However, qXR-CTR offers more flexible deployment options including cloud, on-premise, and hybrid, which caters to a wider range of enterprise IT infrastructures and security policies. This adaptability makes it more suitable for diverse healthcare organizations.

Innovation

ZEUS System

The ZEUS System represents a more significant innovation by combining AI-powered analysis of ECG data with long-term wearable biosensors for continuous cardiac monitoring. This approach shifts the paradigm towards proactive and personalized cardiac care for arrhythmia detection. While qXR-CTR's automation of CTR measurement is valuable, it is a more focused application compared to the transformative potential of continuous physiological monitoring.

Support & Docs

ZEUS System

Both companies provide comprehensive documentation, including Instructions for Use and user manuals. However, iRhythm Technologies, with its ZEUS System, also offers patient-specific support and FAQs, which is a crucial advantage given the patient-facing nature of its wearable monitoring devices. This broader scope of support resources gives Tool A a slight edge.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System qXR-CTR
Tool Name ZEUS System qXR-CTR
Company iRhythm Technologies Qure.ai Technologies
Primary Function AI-powered software analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
Tagline AI-powered cardiac monitoring for early arrhythmia detection and management. AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment.
Key Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring ZEUS System and qXR-CTR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ZEUS System is an AI-powered software designed for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation from ECG data. In contrast, qXR-CTR is an AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, assisting in the assessment of heart size and potential heart failure risk.
The ZEUS System analyzes ECG data collected from wearable biosensors for continuous cardiac monitoring. qXR-CTR, on the other hand, processes chest X-ray images to measure the cardiothoracic ratio.
The ZEUS System supports HL7-based EHR integration and integrates with Zio Watch and Zio monitors. qXR-CTR provides annotated X-rays and structured reports in DICOM and JSON formats, integrating seamlessly into existing radiology workflows, and also supports HL7 v2 and FHIR data standards.
The ZEUS System is intended for use across Cardiology, Family Medicine, and Internal Medicine. qXR-CTR primarily serves Cardiology and Radiology specialties.
Yes, the ZEUS System provides continuous ECG monitoring for up to 14 days, supporting the detection of both symptomatic and asymptomatic cardiac events. qXR-CTR, however, automates a single-point measurement from a chest X-ray image and is not designed for continuous monitoring.
The ZEUS System generates preliminary reports for physicians based on its AI-powered arrhythmia detection and characterization. qXR-CTR provides annotated X-rays and structured reports in DICOM and JSON formats, including the calculated cardiothoracic ratio, to aid in assessing heart size and potential heart failure risk.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.